Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond



Rating:

Share or cite this content

Citations should be made in the following way:
E. Jutant (Le Kremlin Bicêtre, France), A. Roche (Le Kremlin Bicêtre, France), A. Boucly (Le Kremlin Bicêtre, France), A. Camboulive (Le Kremlin Bicêtre, France), M. Jevnikar (Le Kremlin Bicêtre, France), X. Jais (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), L. Savale (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France). Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension. 3599

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension associated with Whipple disease Source: Eur Respir Rev 2014; 23: 533-536 Year: 2014 Abernethy syndrome: A rare cause of pulmonary hypertension Source: International Congress 2018 – Paediatric bronchology Year: 2018 Reversible pulmonary hypertension associated with multivisceral Whipple's disease Source: Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020 Year: 2021 Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015 Pulmonary hydatid disease: a unique treatment for an uncommon disease Source: Eur Respir J 2007; 30: Suppl. 51, 392s Year: 2007 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007 Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis Source: Eur Respir J 2009; 33: 517-520 Year: 2009 A rare form of pulmonary hypertension or a rare presentation of a common disease? Source: Annual Congress 2011 - Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Pulmonary Hypertension in the Clinic Grand Round - an interactive session Year: 2011 Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 177-180 Year: 2009 Pulmonary arterial hypertension masquerading as severe refractory asthma Source: Eur Respir J 2008; 32: 513-516 Year: 2008 Pulmonary complications of Behcet disease Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Haemoptysis in pulmonary arterial hypertension (PAH): a life-threatening complication Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Management of life-threatening hemoptysis in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Occult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension Source: ERJ Open Res, 5 (4) 00157-2019; 10.1183/23120541.00157-2019 Year: 2019 Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016 Year: 2017 Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease Source: Eur Respir J 2015; 45: 842-845 Year: 2015